Methods |
Identification of subsequent full‐length publications
|
Data |
Included 82 abstracts presented at the 1987, 1998 and 1999 International Continence Society meetings
Included all abstracts of randomized controlled trials
|
Comparisons |
Proportion of abstracts published
Mean time to publication
'Positive' versus not 'positive'
Sample size greater than 100 versus sample size at or below 100
Oral versus poster presentation
Presence of allocation concealment versus no or unsure allocation concealment
Presence of blinded treatment administrator versus no or unsure treatment administrator
Presence of blinded outcome assessor versus no or unsure blinded outcome assessor
Proportion of withdrawals
Use of placebo
Device versus drug versus neither as intervention
Use of subjective outcome
Multi‐centered versus single center
'Company' funding versus none
|
Outcomes |
41 of 82 abstracts published
-
Proportion of abstracts published by time
-
Factors related to proportion of abstracts published from 1998 and 1999 International Continence Society meetings included
20/49 'positive' (defined as experimental better than control) versus 5/14 not 'positive' abstract results published
14/27 abstracts with sample size greater than 100 versus 10/34 abstracts with sample size of 100 or less published
4/10 abstracts presented orally versus 18/43 abstracts presented as posters published
7/20 abstracts with allocation concealment present versus 18/43 abstracts with no or unsure allocation concealment published
7/21 abstracts with blinded treatment administrator versus 18/42 abstracts with no or unsure treatment administrator published
0/7 abstracts with blinded outcome assessor versus 25/56 abstracts with no or unsure blinded outcome assessor published
11/23 abstracts with multiple centers versus 14/40 abstracts with a single center published
3/16 abstracts with 'company' funding versus 22/47 abstracts without 'company' funding published
|
Notes |
Urology ‐ incontinence
Funding by university
|
Risk of bias |
Item |
Authors' judgement |
Description |
Sampling method? |
Yes |
Included all abstracts that described specific study design, so low risk of bias. |
Search for publications? |
Yes |
Searched 6 databases and contacted abstract authors. |
Follow‐up time? |
Yes |
All meetings had at least 6 years follow‐up. |
Matching? |
Yes |
Matched by 2 different criteria. |
Adjustment for confounding? |
No |
Examined association of positive results, sample size, type of presentation, multi‐center status, funding status, and presence of blinding for treatment administrator, or outcome assessor, proportion of withdrawals, use of placebo, type intervention, and use of subjective outcome with publication using stratified analysis and Chi2 tests. |